Moro P, Schantz PM, 2006. Cystic echinococcosis in the Americas. Parasitol Int 55: S181–S186.
Thompson RC, Boxell AC, Ralston BJ, Constantine CC, Hobbs RP, Shury T, Olson ME, 2006. Molecular and morphological characterization of Echinococcus in cervids from North America. Parasitology 132: 439–447.
Jenkins DJ, Romig T, Thompson RC, 2005. Emergence/re-emergence of Echinococcus spp.: a global update. Int J Parasitol 35: 1205–1219.
Somily A, Robinson JL, Miedzinski LJ, Bhargava R, Marrie TJ, 2005. Echinococcal disease in Alberta, Canada: more than a calcified opacity. BMC Infect Dis 5: 34.
Finlay JC, Speert DP, 1992. Sylvatic hydatid disease in children: case reports and review of endemic Echinococcus granulosus infection in Canada and Alaska. Pediatr Infect Dis J 11: 332–336.
Wolfgang RW, Poole JB, 1956. Distribution of Echinococcus disease in northwestern Canada. Am J Trop Med Hyg 5: 869–871.
Unruh DH, Kink JE, Eaton RD, Allen JR, 1973. Parasites of dogs from Indian settlements in northwestern Canada: a survey with public health implications. Can J Comp Med 37: 25–32.
Coltorti E, Fernandez E, Guarnera E, Lago J, Iriarte J, 1988. Field evaluation of an enzyme immunoassay for detection of asymptomatic patients in a hydatid control program. Am J Trop Med Hyg 38: 603–607.
Coltorti EA, 1986. Standardization and evaluation of an enzyme immunoassay as a screening test for the seroepidemiology of human hydatidosis. Am J Trop Med Hyg 35: 1000–1005.
Trachsel D, Deplazes P, Mathis A, 2007. Identification of taeniid eggs in the faeces from carnivores based on multiplex PCR using targets in mitochondrial DNA. Parasitology 134: 911–920.
Cox DD, Todd AC, 1962. Survey of gastrointestinal parasitism in Wisconsin dairy cattle. J Am Vet Med Assoc 141: 706–709.
Petrie A, Watson P, 2006. Statistics for Veterinary and Animal Sciences. Second edition. Ames, IA: Blackwell, 55–173.
Lavikainen A, Lehtinen MJ, Meri T, Hirvela-Koski V, Meri S, 2003. Molecular genetic characterization of the Fennoscandian cervid strain, a new genotypic group (G10) of Echinococcus granulosus. Parasitology 127: 207–215.
Campos-Bueno A, Lopez-Abente G, Andres-Cercadillo AM, 2000. Risk factors for Echinococcus granulosus infection: a case-control study. Am J Trop Med Hyg 62: 329–334.
Past two years | Past Year | Past 30 Days | |
---|---|---|---|
Abstract Views | 5 | 5 | 5 |
Full Text Views | 530 | 274 | 1 |
PDF Downloads | 164 | 72 | 1 |
Within a remote Canadian Indigenous community, at least 11* of people had antibodies against Echinococcus granulosus and E. granulosus eggs were detected in 6* of environmentally collected canine fecal samples. Dog ownership, hunting, and trapping were not risk factors for seropositivity, suggesting that people are most likely exposed to E. granulosus through indirect contact with dog feces in the environment. In this situation, human exposure could be most effectively curtailed by preventing consumption of cervid viscera by free-roaming dogs.
Financial support: This study was supported by the Division of Infectious Diseases, Royal University Hospital and the Western College of Veterinary Medicine Interprovincial Graduate Fellowship for Veterinarians.
Authors' addresses: Chelsea G. Himsworth and Frederick A. Leighton, Department of Veterinary Pathology, University of Saskatchewan, Saskatoon, Saskatchewan, Canada, E-mails: chelsea.himsworth@usask.ca and ted.leighton@usask.ca. Emily Jenkins, Janet E. Hill, and Brent A. Wagner, Department of Veterinary Microbiology, University of Saskatchewan, Saskatoon, Saskatchewan, Canada, E-mails: emily.jenkins@usask.ca, janet.hill@usask.ca, and brent.wagner@usask.ca. Mandiangu Nsungu, Northern Inter-Tribal Health Authority, Prince Albert, Saskatchewan, Canada, E-mail: mnsungu@nitha.com. Momar Ndao, National Reference Centre for Parasitology, Montreal General Hospital, Montreal, Quebec, Canada, E-mail: momar.ndao@mcgill.ca. R. C. Andrew Thompson, Catherine Covacin, and Amanda Ash, World Health Organization Collaborating Centre for the Molecular Epidemiology of Parasitic Infections, School of Veterinary and Biomedical Sciences, Murdoch University, Western Australia, Australia, E-mails: a.thompson@murdoch.edu.au, c.covacin@murdoch.edu.au, and A.Ash@murdoch.edu.au. Athena McConnell and Stuart Skinner, Division of Infectious Diseases, Royal University Hospital, Saskatoon, Saskatchewan, Canada, E-mails: Athena.McConnell@saskatoonhealthregion.ca and Stuart.Skinner@saskatoonhealthregion.ca.